India·Source-based summary

Bharat Biotech arm Nucelion, VeGen Bioto partner for CAR-T therapy

Nucelion will serve as the technology transfer and clinical as well as commercial stage manufacturing partner for VeGen Bio’s lead candidate, VL-2511, for multiple myeloma

This is a source-based summary, not original reporting by Ebenezer journalists. Source: The Hindu. Ebenezer published 21 Oct 2026, 09:50 am. Editorial policy.

Read the original report on The Hindu →

The Hindu21 Oct 2026, 09:50 amUpdated 1h ago1 min readIndiaIndia

India — The Hindu

Bharat Biotech arm Nucelion, VeGen Bio to partner for CAR-T therapy

Nucelion will serve as the technology transfer and clinical as well as commercial stage manufacturing partner for VeGen Bio’s lead candidate, VL-2511, for multiple myeloma

This report is published with credit to The Hindu. The wire sent a summary; open the original for any extra context. Read on The Hindu →

Source: The Hindu. Published 21 Oct 2026, 09:50 am.

Next news → Former TDP MLA Gunda Lakshmi Devi likely t…Browse more stories

Keep reading

Most relevant

Former TDP MLA Gunda Lakshmi Devi likely to join YSRCP on October 22

She is expected to be the party’s Mayor candidate for the Srikakulam Municipal Corporation

Read on The Hindu →

Editor’s choice

Railways floats tender for track doubling between Aduthurai and Sundaraperumal Koil

Work on the doubling project, estimated at ₹289.17 crore, are expected to commence in January; plan is to complete the project along with electrification in one year

Read on The Hindu →

Also developing

Continuing violence in Manipur an indictment of BJP’s failure of governance: Congress

Congress president Mallikarjun Kharge asked Prime Minister Narendra Modi and Home Minister Amit Shah who would take responsibility for a “monumental failure of governance”, after four civilians were killed in the latest spate of violence in the State

Read on The Hindu →

Back to the desk

info@ebenezerdigital.com +91 98944 96560 WhatsApp

Privacy · Terms · Sitemap